Delhi HC says Indian Payer Alone Cannot Create Taxable Accrual for Non-Resident

The Delhi High Court quashed reassessment proceedings against Teva USA concerning payments arising from pharmaceutical marketing rights and a settlement governed by US arrangements. The Court held that the mere fact that Ranbaxy India made the payment from India could not constitute a universal source rule, particularly where the underlying rights, contractual dispute and commercial activity were situated outside India.